accountAstraZeneca heart disease $1,385 mln dapagliflozin Bristol-Myers/AstraZeneca diabetes $1,267 mln Yervoy Bristol-Myers melanoma $931 mln boceprevir Merck hepatitis C $606 mln abiraterone J&J cancer $456 mln oxycodone Pfizer pain $450 mln Menhibrix...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Factbox: Top new drugs of 2011
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account